NO20076464L - Motilidforbindelser - Google Patents

Motilidforbindelser

Info

Publication number
NO20076464L
NO20076464L NO20076464A NO20076464A NO20076464L NO 20076464 L NO20076464 L NO 20076464L NO 20076464 A NO20076464 A NO 20076464A NO 20076464 A NO20076464 A NO 20076464A NO 20076464 L NO20076464 L NO 20076464L
Authority
NO
Norway
Prior art keywords
motilidforbindelser
compounds
useful
formula
structure according
Prior art date
Application number
NO20076464A
Other languages
English (en)
Inventor
Yaoquan Liu
Christopher Carreras
David C Myles
Yong Li
Simon James Shaw
Hong Fu
Yue Chen
Hao Zheng
Yandong Li
Mark A Burlingame
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20076464L publication Critical patent/NO20076464L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Forbindelser som har en struktur i henhold til formel (I) hvor RA, RB, Rc, RD, RE og RF er som definert heri, er anvendelige som prokinetiske midler.
NO20076464A 2005-05-24 2007-12-14 Motilidforbindelser NO20076464L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US68461205P 2005-05-24 2005-05-24
US71540605P 2005-09-08 2005-09-08
US74889805P 2005-12-08 2005-12-08
US11/416,519 US7582611B2 (en) 2005-05-24 2006-05-02 Motilide compounds
PCT/US2006/017672 WO2006127252A1 (en) 2005-05-24 2006-05-08 Motilide compounds

Publications (1)

Publication Number Publication Date
NO20076464L true NO20076464L (no) 2008-02-22

Family

ID=37452327

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076464A NO20076464L (no) 2005-05-24 2007-12-14 Motilidforbindelser

Country Status (19)

Country Link
US (1) US7582611B2 (no)
EP (1) EP1888082B1 (no)
JP (1) JP4197359B2 (no)
KR (1) KR100956465B1 (no)
AP (1) AP2337A (no)
AU (1) AU2006249555B2 (no)
BR (1) BRPI0611374A2 (no)
CA (1) CA2609494C (no)
CU (1) CU23750B7 (no)
EA (1) EA014711B1 (no)
ES (1) ES2392860T3 (no)
GE (1) GEP20094854B (no)
IL (1) IL186752A (no)
MA (1) MA29485B1 (no)
MX (1) MX2007014255A (no)
NO (1) NO20076464L (no)
NZ (1) NZ562891A (no)
TN (1) TNSN07436A1 (no)
WO (1) WO2006127252A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ568763A (en) * 2005-12-08 2010-04-30 Pfizer Method for demethylating the 3'-dimethylamino group of erythromycin compounds
EP2431380A3 (en) 2006-09-11 2013-07-03 Tranzyme Pharma, Inc. Macrocyclic antagonist of the motilin receptor for treatment of gastrointestinal dysmotility disorders
ES2401467T3 (es) 2006-12-05 2013-04-19 Bristol-Myers Squibb Company Polimorfos de motilida
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
EP2401268B1 (en) 2009-02-27 2015-07-29 RaQualia Pharma Inc Oxyindole derivatives with motilin receptor agonistic activity
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
AR080055A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1
ES2527849T3 (es) 2010-02-02 2015-01-30 Novartis Ag Derivados de ciclohexilamida como antagonistas del receptor de CRF

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU35369B (en) 1973-01-19 1980-12-31 Pliva Zagreb Process for preparing n-(benzenesulfonyl)-erythromycilamine derivatives
US3983103A (en) 1973-01-19 1976-09-28 Pliva Pharmaceutical And Chemical Works N-(Benzenesulfonyl)-erythromycylamine derivatives
US3855200A (en) 1973-04-23 1974-12-17 Polska Akademia Nauk Instytut Process for preparing 8-hydroxyerthromycin a and intermediates therefor
YU35363B (en) 1974-01-14 1980-12-31 Pliva Zagreb Process for obtaining n-(benzene-sulfonyl)-5-0desosaminyl-erythromycilamine derivatives
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
IT1196041B (it) 1984-03-08 1988-11-10 Pierrel Spa Emichetali di (8s)-8-fluoroeritromicine,il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che contengono i prodotti
JPS60218321A (ja) 1984-04-13 1985-11-01 Satoshi Omura 消化管収縮運動促進剤
US5008249A (en) 1985-08-31 1991-04-16 Kitasato Kenkyusho Therapeutic method of stimulating digestive tract contractile motion in mammals
US5175150A (en) 1985-08-31 1992-12-29 Kitasato, Kenkyusho Erythromycin derivative
IL99995A (en) 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
ATE139697T1 (de) 1991-04-09 1996-07-15 Abbott Lab Macrozyklische laktam-prokinetika
US5554605A (en) 1991-04-09 1996-09-10 Abbott Laboratories Macrocyclic lactam prokinetic agents
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE69317877T2 (de) 1992-01-21 1998-10-29 Abbott Lab 4''-deoxyerythromycinderivate
DE69302938T2 (de) 1992-03-19 1996-10-17 Kitasato Inst Erythromycinderivate, Herstellung und Verwendung davon
MY113693A (en) 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
ZA966601B (en) 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
WO1997042204A1 (en) 1996-05-07 1997-11-13 Abbott Laboratories 6-o-substituted erythromycins and method for making them
US5712253A (en) 1996-06-18 1998-01-27 Abbott Laboratories Macrocyclic 13-membered ring derivatives of erythromycins A and B
DK0910633T3 (da) * 1996-07-05 2010-03-29 Biotica Tech Ltd Hybrid polyketidsyntase I-gen
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
US5922849A (en) 1996-11-22 1999-07-13 Abbott Laboratories Process for preparation of N-demethyl-4"-deoxy-erthromycins A and B
US6169168B1 (en) 1997-10-29 2001-01-02 Taisho Pharmaceuticals Co., Ltd. Erythromycin A derivatives
US6084079A (en) 1998-05-15 2000-07-04 Keyes; Robert F. Process for preparing N-demethyl-N-alkyl erythromycin derivatives
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6562795B2 (en) 2000-02-18 2003-05-13 Kosan Biosciences, Inc. Motilide compounds
AU8257701A (en) * 2000-09-01 2002-03-13 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivative
US20020094962A1 (en) 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
CA2437576A1 (en) 2001-02-15 2002-08-22 Kosan Biosciences, Inc. Method for evaluating therapeutic efficacy
JP2002241391A (ja) 2001-02-15 2002-08-28 Taisho Pharmaceut Co Ltd エリスロマイシンａ誘導体
WO2004019879A2 (en) 2002-08-29 2004-03-11 Kosan Biosciences, Inc. Motilide compounds
US20050113319A1 (en) 2003-08-26 2005-05-26 Christopher Carreras 11-Deoxy-6,9-ether erythromycin compounds
US7407941B2 (en) 2003-08-26 2008-08-05 Pfizer, Inc. N-desmethyl-N-substituted-11-deoxyerythromycin compounds
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
US7211568B2 (en) 2003-12-18 2007-05-01 Kosan Biosciences Incorporated 9-Desoxoerythromycin compounds as prokinetic agents
US20060075011A1 (en) * 2004-09-23 2006-04-06 Fujitsu Limited System and method for optimizing polynomial expressions in a processing environment
TW200633714A (en) 2004-12-28 2006-10-01 Chugai Pharmaceutical Co Ltd Drugs for the treatment and/or prophylaxis of gastroparesis symptom

Also Published As

Publication number Publication date
US20060270616A1 (en) 2006-11-30
CU20070261A7 (es) 2009-07-16
AP2337A (en) 2011-12-14
JP2008542268A (ja) 2008-11-27
EA200702290A1 (ru) 2008-04-28
CA2609494C (en) 2010-12-21
IL186752A0 (en) 2008-02-09
HK1117739A1 (en) 2009-01-23
TNSN07436A1 (fr) 2009-03-17
ES2392860T3 (es) 2012-12-14
AU2006249555B2 (en) 2009-07-16
CA2609494A1 (en) 2006-11-30
MA29485B1 (fr) 2008-05-02
AU2006249555A1 (en) 2006-11-30
WO2006127252A1 (en) 2006-11-30
EA014711B1 (ru) 2011-02-28
JP4197359B2 (ja) 2008-12-17
GEP20094854B (en) 2009-12-10
EP1888082A4 (en) 2008-12-17
KR100956465B1 (ko) 2010-05-07
NZ562891A (en) 2011-01-28
MX2007014255A (es) 2008-01-22
IL186752A (en) 2011-10-31
EP1888082A1 (en) 2008-02-20
US7582611B2 (en) 2009-09-01
CU23750B7 (es) 2012-01-31
AU2006249555A8 (en) 2006-11-30
EP1888082B1 (en) 2012-09-12
AP2007004220A0 (en) 2007-10-31
KR20080013922A (ko) 2008-02-13
BRPI0611374A2 (pt) 2010-08-31

Similar Documents

Publication Publication Date Title
NO20084583L (no) Makrosykliske kinase-inhibitorer
LTC1912503I2 (lt) Fungicidiniai mišiniai, turintys 1-metilpirazol-4-ilo karboksirūgšties anilidus
NO20082793L (no) Nye tiofenderivater
DK1948149T4 (da) Formulering, som omfatter metformin og vildagliptin
DK2134699T3 (da) 2-aryl-5-heterocyclyl-cyclohexan-1,3-dion som indeholder 1,3-dion-forbindelser og deres anvendelse som herbicider
LTPA2016036I1 (lt) Nitrokatechnolio dariniai, kaip COMT inhibitoriai
SI3670528T1 (sl) Sredstva, ki vežejo sklerostin
DK1849470T4 (en) Cancerlægemiddel, som indeholder alpha, alpha, alpha-trifluorthymidin og thymidin-phosphorylase-inhibitor
DK1856042T3 (da) Substituerede gamma-lactamer som terapeutiske midler
DK1960352T3 (da) 2-adamantylurinstof-derivater som selektive 11beta-hsd1 inhibitorer
DK1904475T3 (da) N-thioanthranilamid-forbindelser og deres anvendelse som pesticider
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
ATE490254T1 (de) Imidazoä1,2-aüpyridin-verbindungen als vegf-r2- hemmer
DK2380887T3 (da) Fremgangsmåder til fremstilling af 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindolin-1,3-dion-forbindelser
DK1863812T3 (da) Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler
DK1937671T3 (da) Benzimidazolthiophenforbindelser som PLK-inhibitorer
NO20090173L (no) Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes
NO20082298L (no) Kaliumkanalinhibitorer
DK1928840T3 (da) 1H-pyrazol-4-carboxamider, deres fremstilling og deres anvendelse som 11-beta-hydroxysteroid-dehydrogenaseinhibitorer
DK3275965T3 (da) Sammensætninger, der omfatter en fluorolefin
DK2041069T3 (da) Benzylaminer, fremgangsmåde til fremstilling deraf og deres anvendelse som anti-inflammatoriske midler
DK2407451T3 (da) N,N-substituerede 3-aminopyrrolidin-forbindelser anvendelige som monoamin-genoptagelseshæmmere
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
CU20070261A7 (es) Compuestos de motilida

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application